VistaGen Therapeutics Inc (VTGN)
2.16
-0.03 -1.37%
NASDAQ
Apr 9, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.26 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -14.99M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -1.69K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 310.53M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | -- |
| PE Ratio | -- |
| Price to Book Value | 3.310 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.001 |
| Free Cash Flow (Quarterly) | -5.140M |
| Return on Equity | Upgrade |
View All VTGN News
News
-
WireHeadlineTime (ET)
-
Yahoo03/31 22:30
-
Globe Newswire03/22 08:30
-
Globe Newswire03/16 07:46
-
MT Newswires03/16 03:04
-
SA Breaking News03/16 02:52
-
MT Newswires03/11 15:57
-
MT Newswires03/11 13:28
-
MT Newswires03/11 11:14
-
Globe Newswire03/11 08:30
-
Yahoo03/11 08:17
-
SA Breaking News02/18 12:40
-
Yahoo02/18 12:00
-
SA Breaking News02/18 11:01
-
MT Newswires02/18 10:23
-
Yahoo02/18 10:02
-
PR Newswire02/18 08:30
-
SA Breaking News02/18 08:26
-
SA Breaking News02/18 07:13
-
Yahoo02/15 08:05
-
Yahoo02/11 17:55
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 06/29/2020 00:00 | Earnings Results | Q4 2020 Earnings Results |
| 08/13/2020 00:00 | Earnings Results | Q1 2021 Earnings Results |
| 09/17/2020 10:00 PDT | Agm | 2020 Annual General Meeting |
| 11/12/2020 00:00 | Earnings Results | Q2 2021 Earnings Results |
| 02/11/2021 00:00 | Earnings Results | Q3 2021 Earnings Results |
| 06/29/2021 00:00 | Earnings Results | Q4 2021 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.vistagen.com
- Investor Relations URL: N/A
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Jun. 29, 2021
- Last Earnings Release: Feb. 11, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants. The PH94B is a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia; PH10 is an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.16 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VTGN Tweets Stocktwits
Advertisement
